Effect of a new nonionic contrast agent, ioxilan, on human erythrocytes and the hemostatic and serum complement pathways. | Invest Radiol;23 Suppl 1: S182-5, 1988 Sep. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Effect of a new nonionic contrast agent, ioxilan, on human erythrocytes and the hemostatic and serum complement pathways.

Parvez, Z; Patel, N B.

Affiliation

Parvez Z; Radiology Research Laboratory, VA Hospital, Hines, IL 60141.

Invest Radiol ; 23 Suppl 1: S182-5, 1988 Sep.

Article in En | MEDLINE | ID: mdl-3198340

Subject(s)

Complement Activation/drug effects; Contrast Media/pharmacology; Erythrocytes/drug effects; Hemostasis/drug effects; Iohexol/analogs & derivatives; Humans; In Vitro Techniques; Iohexol/pharmacology; Iopamidol/pharmacology

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Iohexol / Complement Activation / Contrast Media / Erythrocytes / Hemostasis Limits: Humans Language: En Journal: Invest Radiol Year: 1988 Document type: Article Country of publication: United States

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Iohexol / Complement Activation / Contrast Media / Erythrocytes / Hemostasis Limits: Humans Language: En Journal: Invest Radiol Year: 1988 Document type: Article Country of publication: United States